# FDA warns GLP-1 drugs may raise risk of rare vision-loss condition

https://mins.news/en/item/137517

- Ars Technica, 2026-11-10 14:43 UTC
- Health
- Original: https://arstechnica.com/health/2026/11/glp-1-drugs-may-increase-risk-of-vision-loss-from-rare-condition-fda-warns/

> The FDA says popular GLP-1 drugs, including Ozempic, Wegovy, Zepbound and Mounjaro, may increase the risk of a rare eye condition that can cause permanent vision loss. It will require manufacturers to add a warning to drug labels, though whether the medicines are linked to the condition remains uncertain.

## Related coverage

- [FDA orders new eye-condition warning for Ozempic, Wegovy and other GLP-1 drugs](https://mins.news/en/video/137832) — ABC News, 2026-11-10
- [Makers of GLP-1 drugs ordered to warn of rare eye condition](https://mins.news/en/item/137917) — BBC News, 2026-11-10
- [US FDA orders new eye-risk warnings for Ozempic and Zepbound](https://mins.news/en/item/135774) — Reuters, 2026-11-09
